Thrivent Financial For Lutherans Harmony Biosciences Holdings, Inc. Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 29,535 shares of HRMY stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29,535
Previous 23,655
24.86%
Holding current value
$1.04 Million
Previous $946,000
7.4%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding HRMY
# of Institutions
255Shares Held
46.6MCall Options Held
119KPut Options Held
50K-
Valor Management LLC Chicago, IL6.62MShares$234 Million92.04% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$206 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$167 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.28MShares$80.5 Million0.19% of portfolio
-
State Street Corp Boston, MA1.58MShares$55.8 Million0.0% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.09B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...